Activity Overview
This online, on-demand virtual symposium brings together renowned experts in cardiometabolic disease. In this educational program, these experts use a case-based format to discuss the latest data on the management of these disorders, share their perspectives and best practices, and forecast applications of key clinical challenges and questions in the interdisciplinary care of patients with combinations of cardiometabolic diseases.
This educational activity is an archive of the live presentation held on June 23, 2026.
Target Audience
This educational activity is directed toward NPs, PAs, and nurses. Other health care professionals involved in the care of patients with cardio-renal-metabolic diseases, including cardiologists, nephrologists, and primary care physicians, are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Explain the role of guideline-directed decision-making in selecting sodium-glucose cotransporter 2 (SGLT2) inhibitor therapy for patients with heart failure (HF) and chronic kidney disease (CKD)
- Apply strategies for monitoring in patients treated with guideline-recommended agents for HF and CKD
- Design approaches for optimizing multidisciplinary care models and patient counseling in the clinical context of cardio-kidney-metabolic (CKM) disorders
Katherine E. Di Palo, PharmD, MBA, MS
Senior Director, Transitional Care
Excellence
Montefiore Medical Center
Associate Professor
Albert Einstein College of Medicine
Bronx, NY
Disclosures: Advisor, Consultant, Fee for Service Recipient: AstraZeneca, scPharmaceuticals, SQ Innovation; Grant/Research Funding (to institution): AstraZeneca
Nancy M. Albert, PhD, APRN-CCNS, CHFN, CCRN, NE-BC, FCCM, FAHA, FHFSA, FAAN
Assoc. CNO/Executive Director, Nursing
Research & Innovation
Clinical Nurse Specialist, Kaufman
Center for Heart Failure Treatment and Prevention
Consultant Staff, Cleveland Clinic
Research
Cleveland, OH
Disclosures: Advisor, Consultant, Fee for Service Recipient: AstraZeneca, Boehringer Ingelheim, BridgeBio, Merck; Grant/Research Funding (to institution): Roche; Royalty or Patent Benefits: Jones & Bartlett Publishers, Springer
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Associate Professor of Research
Intermountain Health
Co-Director of the Advanced Lipid and
Cardiovascular Prevention Clinic
Intermountain Medical Center
Salt Lake City, UT
Disclosures: Advisor, Consultant, Fee for Service Recipient: Amarin, Amgen, Bayer, Boehringer Ingelheim, Esperion, Idorsia, iRhythm, Merck, Novo Nordisk, Novartis; Grant/Research Funding (to institution): Janssen, Kardia/AliveCor; Executive Role: Ocatvian Solutions
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited activity has been developed in accordance with applicable accreditation standards to ensure balance, independence, objectivity, and scientific rigor. Faculty were instructed to use generic names where possible and to base recommendations on the best available evidence.
In the context of clinical discussion, proprietary product names may be mentioned. Such references are made for educational purposes only and do not constitute endorsement of any commercial product or service.
Learners are encouraged to independently evaluate the information presented and apply their own clinical judgment when considering patient care decisions.
This accredited CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing medical and/or nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to the diagnostic, treatment, and management options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any of the companies that provided commercial support for this activity.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
